相关实验视频

Updated: Jul 9, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

纳米载体介导的免疫细胞死亡用于黑色素瘤治疗

Jiandong Wang^1,2,3, Jinyuan Ma^1,4, Zongguang Tai^1,4

¹Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, People's Republic of China.

International journal of nanomedicine

|December 7, 2023

概括

本综述探讨了纳米技术如何增强免疫细胞死亡 (ICD),通过使癌细胞对免疫系统更加可见,从而改善黑色素瘤免疫疗法.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
纳米技术纳米技术

背景情况:

黑色素瘤是一种具有攻击性的皮肤癌,其特点是异质性,高突变率和免疫逃避.
目前针对黑色素瘤的免疫疗法在充分利用免疫系统的抗瘤能力方面存在局限性.
免疫性细胞死亡 (ICD) 提供了一种增强瘤免疫性和改善治疗结果的策略.

研究的目的:

审查癌症治疗中诱导ICD的机制和治疗策略.
探索纳米技术在增强基于ICD的癌症免疫治疗中的作用.
讨论与ICD和潜在的组合疗法相关的免疫应激反应.

主要方法:

文献综述侧重于ICD诱导机制.
分析纳米技术在用于癌症治疗的药物输送中的应用.
检查由ICD和纳米载体利用引发的免疫反应.

主要成果:

基于纳米粒子的策略显示出增强ICD和癌症免疫疗法的前景.
纳米粒子提供了诸如改善血液循环,稳定性和瘤向等优势.
将ICD诱导与纳米载体相结合可能产生协同效应的治疗效益.

结论:

纳米技术支持的ICD是一种有前途的策略,可以克服当前黑色素瘤免疫疗法的局限性.
进一步研究将ICD诱导方法与纳米载体结合起来,有必要进行进一步的癌症治疗.
了解免疫应激反应对于优化基于ICD的治疗方法至关重要.

关键词:

损害与此相关的分子模式.免疫性细胞死亡免疫性细胞死亡免疫疗法免疫疗法黑色素瘤是一种黑色素瘤.纳米载体纳米载体是什么

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.